GH Guardant Health


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The annual meeting of stockholders (the “Annual Meeting”) of Guardant Health, Inc. (the “Company”) was held on June 16, 2021.

All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 29, 2021 (the “Proxy Statement”), were elected to serve on the Company’s board of directors by the following vote:

Name of NomineeVotes ForVotes WithheldBroker

Helmy Eltoukhy64,562,53618,099,7485,836,382
AmirAli Talasaz63,735,52518,926,7595,836,382
Bahija Jallal55,404,40227,257,8825,836,382

Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021, was approved by the following vote:

Votes ForVotes AgainstAbstentions

Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, was not approved by the following vote:

Votes ForVotes AgainstAbstentionsBroker